A comprehensive view of sanofi sa. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

New York state attorney general secures deal with Novo Nordisk to cap insulin price at US$35 per monthly prescription for uninsured New Yorkers for five years; the state has similar agreements with Eli Lilly and Sanofi
Published: September 12, 2023 by US Official News
LIB Therapeutics' injectable PCSK9 inhibitor shows promising results in reducing levels of LDL-cholesterol among patients with high cholesterol in Phase 3 trial; results pave way for competition against cholesterol drugs by Amgen, Regeneron and Sanofi
Published: August 29, 2023 by FierceBiotech
AstraZeneca and Sanofi's Beyfortus approved by FDA for prevention of RSV lower respiratory tract disease in infants up to 24 months; Beyfortus is the first preventive option approved to protect a broad infant population
Published: July 17, 2023 by AstraZeneca AB
European Medicine Agency to monitor safety of GLP-1 diabetes and obesity treatments; Novo Nordisk, Eli Lilly, AstraZeneca, and Sanofi have until July 26 to provide additional information addressing cancer-associated concerns
Published: July 05, 2023 by Indian Pharma Industry: Policies
Sanofi aims to become first pharma firm powered by AI at scale with launch of Plai app from Aily Labs; Sanofi incorporating AI in research, clinical operations and manufacturing.to streamline work processes
Published: June 15, 2023 by FiercePharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count